Navigation Links
Leading Biopharmaceutical Company Selects Stimar for Code of Conduct Regulation Training
Date:11/16/2009

Stimaré’s Interactive Regulatory Compliance Training Provides Critical Strategies for Successful Interactions Between Life Science Companies and Health Care Providers

San Jose, CA (PRWEB) November 16, 2009 -- Stimaré, a specialized sales enablement and IT consulting company, today announced that UCB, a global biopharmaceutical leader selected Stimaré to supplement its compliance training, utilizing their cost effective, interactive, training delivery approach. Stimaré’s expertise in gift ban laws coupled with their convenient training approach meets critical criteria for pharmaceutical and medical device companies who have a need to deliver targeted training.

Stimaré is helping UCB by assisting them in their delivery of state specific compliance training and providing strategies for successful interactions with health care providers (HCP). "We chose to partner with Stimaré because they were willing to work with us to offer our people relevant training over a convenient webinar platform," said Clive Davis UCB Inc. Chief Compliance Officer. He adds, "The interactive nature of the session was well received."

The format of the Stimaré training delivery approach requires less time spent traveling, minimizing time out of the field and is cost effective. Stimaré focuses its compliance training on developing skills and tactics to comply with new state laws governing relationships with HCP’s. The course is designed by Stimaré salespeople to describe the compliance code using real world examples. “The training was well worth our time - we came away with a much better understanding of the laws and how we can work with them,” said Shaun Meehan UCB Sales Manager.

Stimaré training includes situational examples, interactive discussions of common interactions and how to apply the new laws to maximize business and concludes with an online written exam. Each training participant receives a quick reference card with key compliance information, a certificate of completion and reference materials.

About Stimare

Stimaré is a specialized sales enablement consulting company who works with global, midsize and small companies, nationally and internationally. Stimaré helps companies identify and develop account plans, writes custom software applications for salespeople, conducts sales and marketing code of conduct compliance training and provides individual skill development workshops to elevate the results of sales organizations. For more information please visit www.stimareselling.com.

# # #

Read the full story at http://www.prweb.com/releases/2009stimare/11/prweb3209934.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dishler Laser Institute Announces Dr. Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States, as Seen in Forbes Magazine
2. Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center
3. Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.
4. Carefx Named an Innovative Information Access Company to Watch By Leading Market Research Firm
5. Side-Out Foundation teams with leading medical professionals to battle breast cancer
6. Recognizing the Most Brilliant Physicians from Around the Globe, The Leading Physicians of the World, will showcase the Biographies of This Year's Top Internist in Their 2010 Edition
7. PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum
8. Wound Management Technologies Announces Clinical Study Presentation of CellerateRx(R) Technology at Leading Skin and Wound Care Conference
9. Leading Society Publisher, American Academy of Pediatrics, Chooses iPublishCentral to Launch e-Book Strategy
10. Leading Southern California Physicians Report Patient Fears About Complexities of Flu Season
11. Remuda Ranch, Nations Leading Eating Disorder Treatment Center, Finds an Increase in Treating Twins With Eating Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... , ... David J. Dykeman , Ginger Pigott , and ... at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg ... global Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... 10.2 version gives development continuity to its innovative Unified Instance Manager architecture, ... capacity. In addition, this new version optimizes the unattended auto-dialing system without ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to ... convenient service for Texas, they are expanding their presence in Dallas. One of the ... that will bring new jobs to the Dallas and Forth Worth market. STAT takes ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and the Affordable Care Act. Dr. Botelho advocates for the mass media launching ... movement gives people ongoing opportunities to share their unfortunate experiences; such a movement ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... from offices headquartered in Hamilton County, is embarking on a charity drive with ... in finding new homes for orphaned or neglected senior dogs in the Cincinnati ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 Australia Glaucoma Surgery Devices ... new report, "Australia Glaucoma Surgery Devices Market Outlook ... Australia Glaucoma Surgery Devices market. The report provides ... units) and average prices (USD) within market segement ... provides company shares and distribution shares data for ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... to grow in 2017-2023. Various reasons for growth of ... population, higher incidences of chronic diseases, high recovery cost ... aid services. Medical lifting sling refers to an ... limited mobility. These slings connect to the lift and ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology: